Page last updated: 2024-08-24

thiazolyl blue and Carcinoma, Medullary

thiazolyl blue has been researched along with Carcinoma, Medullary in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Böckmann, M; Cranston, AN; Dahmen, U; Drosten, M; Hilken, G; Mise, N; Ponder, BA; Pützer, BM; Rödicker, F	1
Delmore, JE; Hayden, P; Kotoula, V; McMillin, DW; McMullan, C; Mitsiades, CS; Mitsiades, N; Negri, J; Poulaki, V	1

Other Studies

2 other study(ies) available for thiazolyl blue and Carcinoma, Medullary

Article	Year
Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma. Journal of the National Cancer Institute, 2004, Aug-18, Volume: 96, Issue:16 Topics: Adenoviridae; Animals; Bromodeoxyuridine; Carcinoma, Medullary; Cell Division; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Multiple Endocrine Neoplasia Type 2a; Oncogene Proteins; Oncogene Proteins, Fusion; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms	2004
Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:12 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Boronic Acids; Bortezomib; Carcinoma; Carcinoma, Medullary; Cell Line, Tumor; Colorimetry; Doxorubicin; Genes, bcl-2; Humans; Membrane Potentials; Oncogene Protein v-akt; Protease Inhibitors; Pyrazines; RNA, Neoplasm; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Transcription, Genetic	2007

Article

Year

Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.

Journal of the National Cancer Institute, 2004, Aug-18, Volume: 96, Issue:16

Topics: Adenoviridae; Animals; Bromodeoxyuridine; Carcinoma, Medullary; Cell Division; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Multiple Endocrine Neoplasia Type 2a; Oncogene Proteins; Oncogene Proteins, Fusion; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms

2004

Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.

The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:12

Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Boronic Acids; Bortezomib; Carcinoma; Carcinoma, Medullary; Cell Line, Tumor; Colorimetry; Doxorubicin; Genes, bcl-2; Humans; Membrane Potentials; Oncogene Protein v-akt; Protease Inhibitors; Pyrazines; RNA, Neoplasm; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Transcription, Genetic

2007